摘要
预混胰岛素是目前中国应用最广泛的胰岛素起始方案.预混胰岛素类似物可依据基础-餐时部分比例不同分为低预混与中预混两种.前者目前多用于口服降糖药物失效后患者的胰岛素起始治疗方案,而后者目前多被用于每日一次或二次胰岛素治疗方案下血糖控制欠佳患者的胰岛素简约强化治疗方案.
Premixed insulin is currently the most popular insulin starter in China.According to the different ratios of basal and prandial components,premixed insulin analogues could be classified into low-and midmixtures.The former is now mainly used as insulin starter in the patients with type 2 diabetes mellitus after the failure of monotherapy or combination with oral antidiabetic drugs,while the later is usually used as simplified intensive insulin treatment in patients with type 2 diabetes mellitus inadequately controlled on insulin once-or twice-daily.
出处
《中华内分泌代谢杂志》
CAS
CSCD
北大核心
2014年第9期800-803,共4页
Chinese Journal of Endocrinology and Metabolism
关键词
糖尿病
2型
低中比例
预混胰岛素类似物
Diabetes mellitus, type 2
Low-and mid-mixture
Premixed insulin analogues
